Moody's Rating for Premaitha Health

MOODY'S ANALYTICS RISK SCORE

8

Moody’s Daily Credit Risk Score is a 1-10 score of a company’s credit risk, based on an analysis of the firm’s balance sheet and inputs from the stock market. The score provides a forward-looking, one-year measure of credit risk, allowing investors to make better decisions and streamline their work ow. Updated daily, it takes into account day-to-day movements in market value compared to a company’s liability structure.

Premaitha Health Plc engages in the manufacture, development and sale of molecular diagnostic products. It operates through the UK and Rest of the World segments. Its product is IONA test which is marked as non-invasive in vitro diagnostic product for prenatal screening. The company was founded in 2013 and is headquartered in Manchester, the United Kingdom.